Trial Information
Leukemia Cell Cultures for Research of New Anti-cancer Therapies
Inclusion Criteria:
- Patients with suspected de novo or secondary or relapsed acute leukemia, requiring
complementary blood test and bone marrow analysis
- Patients older or equal than 28 days
- Informed consent signed
Exclusion Criteria:
- Pregnancy
- Breastfeeding
Type of Study:
Interventional
Study Design:
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
Principal Investigator
Raoul Herbrecht, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Département d'Hématologie et d'Oncologie-hôpital de Hautepierre Strasbourg, France
Authority:
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study ID:
4452
NCT ID:
NCT00993538
Start Date:
July 2009
Completion Date:
Related Keywords:
- Acute Leukaemia
- Leukaemia
- Blood and marrow cells culture
- Cell growth
- Cell differentiation
- Leukemia